BioSmart Co.Ltd (038460) — Cash Flow Reinvestment Rate
BioSmart Co.Ltd (038460) has a Cash Flow Reinvestment Rate of 0.54x as of September 2025, reinvesting ₩4.12 Billion (capex ₩1.22 Billion plus investments ₩2.90 Billion) from operating cash flow of ₩7.59 Billion. Explore 038460 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
BioSmart Co.Ltd Cash Flow Reinvestment Rate (2010–2024)
Historical reinvestment intensity for BioSmart Co.Ltd across 9 annual periods. Also explore total assets of BioSmart Co.Ltd for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for BioSmart Co.Ltd (2010–2024)
Year-by-year capital reinvestment analysis for BioSmart Co.Ltd. For live market cap and broader valuation context, see 038460 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.60x | ₩17.49 Billion | ₩3.80 Billion | ₩8.66 Billion | ▼ -61.0% |
| 2023 | 11.80x | ₩13.75 Billion | ₩1.17 Billion | ₩4.92 Billion | ▲ +469.2% |
| 2022 | 2.07x | ₩11.58 Billion | ₩5.59 Billion | ₩5.87 Billion | ▼ -60.9% |
| 2021 | 5.30x | ₩6.37 Billion | ₩1.20 Billion | ₩5.22 Billion | ▲ +599.2% |
| 2018 | 0.76x | ₩4.41 Billion | ₩5.81 Billion | ₩3.34 Billion | ▼ -68.1% |
| 2014 | 2.37x | ₩3.10 Billion | ₩1.31 Billion | ₩927.27 Million | ▲ +1120.7% |
| 2013 | 0.19x | ₩748.17 Million | ₩3.85 Billion | ₩748.17 Million | ▲ +87.0% |
| 2012 | 0.10x | ₩895.45 Million | ₩8.62 Billion | ₩895.45 Million | ▼ -16.0% |
| 2010 | 0.12x | ₩589.05 Million | ₩4.76 Billion | ₩589.05 Million | — |